Evaluation of fracture risk in osteoporosis;A csonttörés kockázatának megíté lése osteoporosisban

Orvosi Hetilap

Volumn 152, Issue 33, 2011, Pages 1304-1311

  Szathmári, Miklós ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NONE   (Hungary)

Author keywords

fracture risk; FRAX tool for evaluation of fracture risk; osteoporosis

Indexed keywords

CORTICOSTEROID;

ALCOHOL CONSUMPTION; ARTICLE; BONE DENSITY; FAMILY HISTORY; FOREARM FRACTURE; FRACTURE; HIP FRACTURE; HUMAN; HUMERUS FRACTURE; OSTEOLYSIS; OSTEOPOROSIS; RHEUMATOID ARTHRITIS; RISK FACTOR;

EID: 80051738017     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2011.29191     Document Type: Article

References (41)

1. Cummings, S. R., Melton, L. J.: Epidemiology and outcomes of osteoporotic fractures. Lancet, 2002, 359 (9319), 1761-1767.
2. Johnell, O., Kanis J. A.: Epidemiology of osteoporotic fractures. Osteoporos. Int., 2005, 16, S3-S7. (Pubitemid 46232115)
3. Péntek, M., Horváth, C., Boncz, I. és mtsai: Epidemiology of osteoporosis related fractures in Hungary from the nationwide health insurance database, 1999-2003. Osteoporos. Int., 2008, 19, 243-249.
4. Keene, G. S., Parker, M. J., Pryor, G. A.: Morbidity and mortality after hip fractures. Br. Med. J., 1993, 307, 1248-1250.
5. Center, J. R., Nguyen, T. V., Schneider, D. és mtsai: Mortality after all major types of osteoporotic fracture in men and women: An observational study. Lancet, 1999, 393, 878-882. (Pubitemid 29126875)
6. Cooper, C., Campion, G., Melton, L. J. III: Hip fractures in the elderly: A world-wide projection. Osteoporos. Int., 1992, 2, 285-289.
7. Haney, E. M., Chan, B. K., Diem, S. I. és mtsai: Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch. Intern. Med., 2007, 167, 1246-1251. (Pubitemid 46998495)
8. Ahlborg, H. G., Rosengren, B. E., Järvinen, T. P. és mtsai: Prevalence of osteoporosis and incidence of hip fracture in women - secular trends over 30 years. BMC Musculoskeletal Disord., 2010, 11, 48-54.
9. Kannus, P., Niemi, S., Parkkari, J. és mtsai: Nationwide decline in incidence of hip fracture. J. Bone Miner. Res., 2006, 21, 1836-1838. (Pubitemid 44851558)
10. Schuit, S. C., van der Klift, M., Weel, A. E. és mtsai: Fracture incidence and association with bone mineral density in elderly men and women: The Rotterdam Study. Bone, 2004, 34, 195-202. (Pubitemid 38142449)
11. Delmas, P. D., Seeman, E.: Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Bone, 2004, 34, 599-604. (Pubitemid 38393794)
12. Miller, P. D., Delmas, P. D., Huss, H. és mtsai: Increases in hip and spine bone mineral density are predictive for vertebral antifracture effi cacy with ibandronate. Calcif. Tissue Int., 2010, 87, 305-313.
13. Hans, D., Durosier, C., Kanis, J. A. és mtsai: Assessment of the 10-year probability of osteoporotic hip fracture combining clinical risk factors and heel bone ultrasound: The EPISEM prospective cohort of 12,958 women. J. Bone Miner. Res., 2008, 23, 1045-1051. (Pubitemid 351915726)
14. Garnero, P.: Biomarkers for osteoporosis management: Utility in diagnosis, fracture risk prediction and therapy monitoring. Mol. Diagn. Ther., 2008, 12, 157-170. (Pubitemid 351754589)
15. Hui, S. L., Slemenda, C. W., Johnston, C. C.: Age and bone mass as predictors of fracture in a prospective study. J. Clin. Invest., 1988, 81, 1804-1809.
16. Center, J. R., Bliuc, D., Nguyen, T. V. és mtsa: Risk of subsequent fracture after low-trauma fracture in men and women. JAMA, 2007, 297, 387-394. (Pubitemid 46155800)
17. Kanis, J. A., Johansson, H., Oden, A. és mtsai: A family history of fracture and fracture risk: A meta-analysis. Bone, 2004, 35, 1029-1037. (Pubitemid 39487348)
18. Cumming, S. R., Black, D. M., Nevitt, M. C. és mtsai: Risk factors for hip fracture in white women. N. Engl. J. Med., 1995, 332, 767-773.
19. Dargent-Molina, P., Favier, F., Grandjean, H. és mtsai: Fall-related factors and risk of hip fracture: The EPIDOS prospective study. Lancet, 1996, 348, 145-149. (Pubitemid 26238096)
20. Kanis, J. A., Borgstrom, F., De Laet, C. és mtsai: Assessment of fracture risk. Osteoporos. Int., 2005, 16, 581-589.
21. Cumming, S. R., Black, D. M., Rubin, S. M.: Lifetime risk of hip, Colles', or vertebral fracture and coronary heart disease among Caucasian postmenopausal women. Arch. Intern. Med., 1989, 149, 2445-2448. (Pubitemid 19283200)
22. Kanis, J. A., Johnell, O., Oden, A. és mtsai: Long-term risk of osteoporotic fractures in Malmö. Osteoporos. Int., 2000, 11, 669-674.
23. Kanis, J. A., Borgstrom, F., De Laet, C. és mtsai: Assessment of fracture risk. Osteoporos. Int., 2005, 16, 581-589.
24. Kanis, J. A., McCloskey, E. V., Johansson, H. és mtsai: Development and use of FRAX in osteoporosis. Osteoporos. Int., 2010, 21 (Suppl. 2), 407-413.
25. Kanis, J. A., Oden, A., Johnell, O. és mtsai: The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos. Int., 2007, 18, 1033-1044.
26. Kanis, J. A., McCloskey, E. V., Johansson, H. és mtsai, National Osteoporosis Guideline Group: Case fi nding for the management of osteoporosis with FRAX - assessment and intervention thresholds for the UK. Osteoporos. Int., 2008, 19, 1395-1408.
27. National Osteoporosis Foundation (NOF): Clinician's Guide to prevention and treatment of osteoporosis. National Osteoporosis Fundation, Washington, 2008. www.nof.org
28. Watts, S. B., Siris, E. S., Cummings, S. R. és mtsai: Filtering FRAX®. Osteoporos. Int., 2010, 21, 537-541.
29. Black, D. M., Steinbuch, M., Palermo, L. és mtsai: An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos. Int., 2001, 12, 519-528. (Pubitemid 32777427)
30. Leslie, W. D., Majumdar, S. R., Lix, L. M. és mtsai: High fracture probability with FRAX usually indicates densitometric osteoporosis: Implications for clinical practice. Osteoporos. Int., 2011. (közlés folyamatban)
31. Vestergaard, P.: Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes: A metaanalysis. Osteoporos. Int., 2007, 18, 427-444. (Pubitemid 46354916)
32. Schwartz, A. V., Vittinghoff, E., Bauer, D. C. és mtsai: Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA, 2011, 305, 2184-2192.
33. Cowie, C. C., Rust, K. F., Ford, E. S. és mtsai: Full accounting of diabetes and pre-diabetes in the U.S. population in 1988- 1994 and 2005-2006. Diabetes Care, 2009, 32, 287-294.
34. Van Staa, T. P., Leufkens, H. G., Abenhaim, I. és mtsai: Fracture and oral corticosteroids: Relationship to daily and cumulative dose. Rheumatology, 2000, 39, 1383-1389. (Pubitemid 32045866)
35. Kanis, J. A., Johansson, H., Oden, A. és mtsa: Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos. Int., 2011, 22, 809-816.
36. Ettinger, B., Black, D. M., Dawson-Hughes, B. és mtsai: Updated fracture incidence rates for the US version of FRAX®. Osteoporos. Int., 2010, 21, 25-33.
37. Bolland, M. J., Siu, A. T., Mason, B. H. és mtsai: Evaluation of the FRAX and Garvan fracture risk calculators in older women. J. Bone Miner. Res., 2011, 26, 420-427.
38. Committee for Medicinal Products for Human Use (CHMP): Guideline on the evaluation of medical products in the treatment of primary osteoporosis. CPMP/EWP/552/95/Rev2. London, CHMP.
39. Quandt, S. A., Thompson, D. E., Schneider, D. L. és mstai: Effect of alendronate on vertebral fracture risk in women with bone mineral density T scores of -1.6 to -2.5 at the femoral neck: The Fracture Intervention Trial. Mayo Clin. Proc., 2005, 80, 343-349. (Pubitemid 40316296)
40. McCloskey, E. V., Johansson, H., Oden, A. és mtsai: Effi cacy of clodronate on the risk of hip fracture in elderly women. J. Bone Miner. Res., 2007, 22 (Suppl. 1), S46.
41. Black, D. M., Schwartz, A. V., Ensrud, K. E. és mtsai: Effects of continuing or stopping alendronate after 5 years of treatment: The Fracture Intervention Trial Long-term Extension (FLEX): A randomized trial. JAMA, 2006, 296, 2927-2938. (Pubitemid 46021497)